NIDCR@NIH

@NIDCR

Official Twitter account of National Institute of Dental and Craniofacial Research, lead federal agency for improving the nation's oral health through research.

Bethesda, MD
Vrijeme pridruživanja: prosinac 2009.

Tweetovi

Blokirali ste korisnika/cu @NIDCR

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NIDCR

  1. proslijedio/la je Tweet

    Learn more about 's efforts to broaden the pool of reviewers!

    Poništi
  2. proslijedio/la je Tweet

    Searching for funding just got a little easier with updated NIH Guide search filters!

    Poništi
  3. proslijedio/la je Tweet

    Wondering about the difference between funding opportunity expiration dates vs application due dates?

    Poništi
  4. proslijedio/la je Tweet
    30. sij

    Notice to Extend the Expiration Date of PAR-18-359: NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01-Clinical Trial Required)

    Poništi
  5. proslijedio/la je Tweet
    30. sij

    Notice to Extend the Expiration Date of PAR-18-432: NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required)

    Poništi
  6. proslijedio/la je Tweet
    30. sij

    Notice to Extend the Expiration Date of PAR-18-360: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22-Clinical Trial Required)

    Poništi
  7. proslijedio/la je Tweet

    I am pleased to announce Dr. John Ngai will be joining this spring as director of the . Dr. Ngai’s 25+ yrs of experience will guide his leadership of this project that aims to revolutionize our knowledge of the brain & brain disorders.

    Poništi
  8. proslijedio/la je Tweet
    31. sij

    DYK every 5-6 weeks mice regrow their front ? Humans can’t do it, but it’d be great if we could. A -funded project studies (pink) in mice teeth before (left) & after (right) injury. The goal: advance in people.

    Poništi
  9. proslijedio/la je Tweet

    At this time, the risk to Americans remains low, and we are working to keep it that way. We will continue our work to monitor, respond to, and mitigate the spread of the and ensure that Americans have the most accurate and up-to-date health and travel information.

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    31. sij

    The press briefing on the is now live. Tune in to see & other Members of the President's Task Force provide an update.

    Prikaži ovu nit
    Poništi
  11. 30. sij

    New from 's Ken Yamada: Cell machines clarify molecular mystery, providing new clues about organs' protective barriers

    Poništi
  12. proslijedio/la je Tweet

    1 in 5 people globally suffer from chronic . is committed to finding alternative methods for pain management.

    Poništi
  13. proslijedio/la je Tweet
    24. sij

    Non-communicable diseases–like cardiovascular disease, cancer, and mental health disorders–are the leading cause of death worldwide. As a member of the 's Commission on NCDs, writes about the ongoing global effort to beat these diseases.

    Poništi
  14. proslijedio/la je Tweet

    For one patient ww/ , medical collaboration by researchers & others around world led to cure & regaining ability to walk. Read her story: Stay tuned for Rare Diseaese Day at Feb. 28

    Poništi
  15. proslijedio/la je Tweet

    An estimated 30 million Americans are affect by . On Feb. 28., network with patients, patient advocates, health care providers, researchers and others at Rare Disease Day at NIH, hosted by & . Register today!

    Poništi
  16. proslijedio/la je Tweet

    Need help determining if your research involves human subjects or if it may be considered exempt from federal regulations? NIH has updated its decision tool to reflect changes effective in the 2018 Revised Common Rule, check it out:

    Poništi
  17. proslijedio/la je Tweet

    Make your comments and suggestions heard by 2/15/20 as NIH plans the Inclusion Across the Lifespan II (IAL-II) workshop, focusing on the recruitment of pediatric, geriatric, and other underrepresented participants in clinical studies.

    Poništi
  18. proslijedio/la je Tweet
    Poništi
  19. proslijedio/la je Tweet
    24. sij

    Notice of a Pre-Application Webinar for NIDCR Institutional Training Program FOAs: T32 (PAR-20-044) and T90/R90 (PAR-20-056)

    Poništi
  20. proslijedio/la je Tweet

    Delighted to have presided over the swearing in of new CEO Josh Denny today. has been with since its launch & brings his diverse skillset to ’s effort to build the largest, most comprehensive precision medicine research platform.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·